Design Therapeutics (DSGN)

Design Therapeutics (DSGN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• DSGN last traded at $10.15, -4.96% on the day.
• Design Therapeutics: P/E -8.6.
• Over the past year DSGN returned 51.49%; year to date 8.21%.

Updated 2026-11-03 13:34 UTC